Background. Malaria is an endemic disease present in many areas of Colombia. In the city of Buenaventura (Colombian Pacific), there is a high incidence of malaria cases, with a high number of deaths due to this disease. Some genetic variants provide protection against malaria, as is the case for individuals heterozygous for some haemoglobin variants (HbS, HbC, and β-thalassemias), individuals homozygous and heterozygous for the A- variant of the G6PD gene, and individuals homozygous for the FYBES allele of the Duffy gene. The objective of this research was to establish the prevalence of these variants through molecular characterization in a representative sample of the population of the urban area of Buenaventura.
Methods. A total of 819 individuals selected randomly from each of the 12 communities of the city were included. The analysis at the molecular level was carried out using PCR-RFLP and allele-specific PCR. The contained data were subjected to descriptive, independence and regression analyses. These evaluations were carried out using Arlequin 3.5, SPSS 20 and R 3.4.1.
Results. Frequencies of 3.1%, 2.2%, 72.2%, 2.1%, 2.8%, and 11% were found for the resistance alleles HbS, HbC, Duffy, β-Thalassemia-29, β-thalassemia-88 and G6PD, respectively. For the Duffy gene, there was a higher frequency of the resistance genotype in the entire population, as well as a higher occurrence of the Duffy resistance genotype combination with the G6PD and HbS/C resistance genotypes. In addition, compared with other age groups, adolescents and young adults (13 to 26 years) presented the highest proportion of resistance genotypes. Likewise, compared with other communities, the communities of the insular zone of Buenaventura (1, 2, 4, 5) had the highest proportion of resistance genotypes. These data are important to take into account by health and prevention entities in the city because they reveal age groups and communities more susceptible to infection by malaria in the city of Buenaventura and groups prone to developing and/or propagating genes that can increase the prevalence of haemoglobinopathies in the population in the long term.